These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16615559)

  • 1. [Diagnosis and treatment for EBV-associated lymphoproliferative disease].
    Kawa K
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():682-6. PubMed ID: 16615559
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus-associated B-cell lymphoproliferative disorder in CLL patients after treatment with fludarabine and cyclophosphamide followed by high-dose chemotherapy with autologous stem cell transplantation.
    Jindra P; Koza V; Boudová L; Vozobulová V; Cerná K; Karas M; Lysák D; Svojgrová M
    Bone Marrow Transplant; 2003 May; 31(10):951-2. PubMed ID: 12748677
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease].
    Kawa K
    Rinsho Ketsueki; 2008 Jun; 49(6):390-6. PubMed ID: 18646606
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice.
    Guinness ME; Kenney JL; Reiss M; Lacy J
    Cancer Res; 2000 Oct; 60(19):5354-8. PubMed ID: 11034070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
    Meijer E; Cornelissen JJ
    Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I treat EBV lymphoproliferation.
    Heslop HE
    Blood; 2009 Nov; 114(19):4002-8. PubMed ID: 19724053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.
    Okamura T; Hatsukawa Y; Arai H; Inoue M; Kawa K
    Lancet; 2000 Jul; 356(9225):223-4. PubMed ID: 10963205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
    Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
    Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoproliferative disorders after liver transplantation.
    Leblond V; Choquet S
    J Hepatol; 2004 May; 40(5):728-35. PubMed ID: 15094218
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD; Hsu DT; Kichuk MR; Garvin JH; Stolar CJ; Haddad J; Stylianos S; Michler RE; Chadburn A; Knowles DM; Addonizio LJ
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic active EBV infection].
    Kimura H
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():630-4. PubMed ID: 16615549
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic Epstein-Barr virus infection].
    Imashuku S; Teramura T
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():503-7. PubMed ID: 15861702
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative disorders.
    Swinnen LJ
    Best Pract Res Clin Haematol; 2006; 19(4):839-47. PubMed ID: 16997187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Cell lymphoproliferative disorder not associated with Epstein-Barr Virus in a child with relapsed acute lymphoblastic leukemia.
    Lehrnbecher T; Trusen A; Deinlein F; Höcht B; Marx A; Kühl J
    Med Pediatr Oncol; 2003 Jan; 40(1):13-7. PubMed ID: 12426680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
    Styczynski J; Einsele H; Gil L; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):383-92. PubMed ID: 19558376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases.
    Cohen JI
    Semin Hematol; 2003 Apr; 40(2):116-23. PubMed ID: 12704588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances on diagnosis and therapy of lymphoproliferative disorders after allo-HSCT].
    Gu B; Chen GH; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):538-42. PubMed ID: 24763039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.